South & Central America Pharmaceutical Contract Sales Organizations Market Forecast to 2030
South & Central America Pharmaceutical Contract Sales Organizations Market Forecast to 2030 – Regional Analysis – by Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), and End User (Biopharmaceutical Companies and Pharmaceutical Companies)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Use of Telemedicine and Remote Detailing Drives South & Central America Pharmaceutical Contract Sales Organizations Market
The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organization (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry’s proactive approach to navigating the market’s complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.
South & Central America Pharmaceutical Contract Sales Organizations Market Overview
The pharmaceutical contract sales organizations market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The pharmaceutical contract sales organization market in South & Central America is experiencing significant growth due to the expanding pharmaceutical market, coupled with the rising need for cost-effective sales solutions. Additionally, the economies of many countries in the region are struggling due to the rising prevalence of chronic diseases and aging populations. Changing lifestyle patterns are also influencing the healthcare sectors in these countries, resulting in a higher demand for pharmaceutical products. Pharmaceutical companies are turning to contract sales organizations to effectively promote and distribute their products in this competitive market. Further, people in South & Central America are becoming more concerned about healthcare, and they are willing to spend higher amounts on pharmaceutical products owing to the burgeoning disposable incomes. Contract sales organizations are crucial in reaching out to such an expanding consumer segment. In addition, governments are implementing policies to improve access to healthcare and reduce healthcare costs. Such regulatory changes and reforms in the healthcare sector fuel the demand for the services provided by these organizations, thereby benefiting the pharmaceutical contract sales organization market in the South & Central America.
South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Pharmaceutical Contract Sales Organizations Market Segmentation
The South & Central America pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.
Based on services, the South & Central America pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the South & Central America pharmaceutical contract sales organizations market in 2022.
Based on modules, the South & Central America pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the South & Central America pharmaceutical contract sales organizations market in 2022.
Based on therapeutic area, the South & Central America pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the South & Central America pharmaceutical contract sales organizations market in 2022.
Based on end user, the South & Central America pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the South & Central America pharmaceutical contract sales organizations market in 2022.
Based on country, the South & Central America pharmaceutical contract sales organizations market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America pharmaceutical contract sales organizations market in 2022.
IQVIA Holdings Inc, Pfizer Inc, Sales Focus Inc, and Syneos Health Inc are some of the leading companies operating in the South & Central America pharmaceutical contract sales organizations market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the South & Central America pharmaceutical contract sales organizations market was valued at US$ 344.44 million in 2022 and is expected to reach US$ 621.93 million by 2030, registering a CAGR of 7.7% from 2022 to 2030. Increasing integration of digital technologies and expansion in emerging markets are among the critical factors attributed to the South & Central America pharmaceutical contract sales organizations market expansion.
The future trajectory of the pharmaceutical contract sales organization (CSO) market is distinctly shaped by the strategic trend of expanding into emerging markets. As the global pharmaceutical landscape increases, emerging economies gain prominence, CSOs increasingly recognize the untapped potential in these regions. Emerging markets present opportunities driven by rising healthcare awareness, expanding middle-class populations, and increasing government investments in healthcare infrastructure. By extending their operations into these burgeoning markets, CSOs can capitalize on the growing demand for pharmaceutical products and establish a strong foothold early in markets poised for substantial growth. However, this expansion necessitates a wise understanding of local regulatory landscapes, cultural nuances, and diverse healthcare systems. Successful expansion into emerging markets demands a tailored approach, where CSOs must align their strategies with each region’s unique challenges and opportunities. Furthermore, such expansions position CSOs as crucial players in the global healthcare ecosystem, contributing to revenue growth and the broader goal of improving healthcare accessibility and outcomes in these evolving markets. In essence, the strategic move toward expanding in emerging markets emerges as a forward-looking trend, reflecting the adaptability and foresight of pharmaceutical CSOs in navigating the complexities of a globalized pharmaceutical landscape.
On the contrary, quality issues associated with outsourcing hamper the growth of South & Central America pharmaceutical contract sales organizations market.
Based on services, the South & Central America pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held 69.9% share of South & Central America pharmaceutical contract sales organizations market in 2022, amassing US$ 240.80 million. It is projected to garner US$ 463.72 million by 2030 to expand at 8.5% CAGR during 2022-2030.
Based on modules, the South & Central America pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held 52.3% share of South & Central America pharmaceutical contract sales organizations market in 2022, amassing US$ 180.22 million. It is projected to garner US$ 348.08 million by 2030 to expand at 8.6% CAGR during 2022-2030.
Based on therapeutic area, the South & Central America pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held 35.0% share of South & Central America pharmaceutical contract sales organizations market in 2022, amassing US$ 120.61 million. It is projected to garner US$ 227.56 million by 2030 to expand at 8.3% CAGR during 2022-2030.
Based on end user, the South & Central America pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held 58.3% share of South & Central America pharmaceutical contract sales organizations market in 2022, amassing US$ 200.94 million. It is projected to garner US$ 349.75 million by 2030 to expand at 7.2% CAGR during 2022-2030.
Based on country, the South & Central America pharmaceutical contract sales organizations market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 61.6% share of South & Central America pharmaceutical contract sales organizations market in 2022. It was assessed at US$ 212.23 million in 2022 and is likely to hit US$ 407.22 million by 2030, exhibiting a CAGR of 8.5% during 2022-2030.
Key players operating in the South & Central America pharmaceutical contract sales organizations market are IQVIA Holdings Inc, Pfizer Inc, Sales Focus Inc, and Syneos Health Inc, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
5. South & Central America Pharmaceutical Contract Sales Organizations Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market – South & Central America Analysis
6.1 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 – 2030
7. South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Services
7.1 Overview
7.2 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Modules
8.1 Overview
8.2 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by Therapeutic Area
9.1 Overview
9.2 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopaedic Diseases: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
11. South & Central America Pharmaceutical Contract Sales Organizations Market – Country Analysis
11.1 South & Central America Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1 Brazil
11.1.1.1 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5 Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.2 Argentina
11.1.2.1 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.2 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.2.3 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.2.4 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.2.5 Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.3 Rest of South & Central America
11.1.3.1 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.2 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.3.3 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.3.4 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.3.5 Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 IQVIA Holdings Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Syneos Health Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sales Focus Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
LIST OF TABLES
Table 2. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 6. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 7. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 10. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Services – Revenue and Forecast to 2030 (US$ Million)
Table 11. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Modules – Revenue and Forecast to 2030 (US$ Million)
Table 12. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area – Revenue and Forecast to 2030 (US$ Million)
Table 13. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 15. Glossary of Terms, South & Central America Pharmaceutical Contract Sales Organizations Market
Â
LIST OF FIGURES
Figure 2. South & Central America – PEST Analysis
Figure 3. South & Central America Pharmaceutical Contract Sales Organizations Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 – 2030
Figure 6. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: South & Central America Pharmaceutical Contract Sales Organizations Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. South & Central America Pharmaceutical Contract Sales Organizations Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 24. South & Central America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. Brazil: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Argentina: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Rest of South & Central America: South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
1. IQVIA Holdings Inc
2. Pfizer Inc
3. Sales Focus Inc
4. Syneos Health Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.